The true cost of low prices

on June 16, 2015 Translation as an investment, Watching and reading and Tags: , with 0 comments

That’s a quote from the president of ATA at the Interpret America conference, and it struck a chord with me. It encapsulates something that I’ve been trying to tease out recently when it comes to how much to pay for translation. It sounds like a ridiculously simple question, but what is the relationship between quality […]

Read more

Orphan drugs and regulatory affairs

on May 19, 2015 Watching and reading and Tags: with 0 comments

I watched the live broadcast of “Orphan Drug & Rare Disease Development: Understanding the European and US Regulatory Landscape” today, hosted by XTalks and presented by Premier Research. Talking about the US regulatory scene, Nach Dave emphasised that orphan drugs spend less time in clinical trials, have a better chance of obtaining FDA approval, and […]

Read more